Andexanet Alfa for Factor Xa Inhibitor Reversal

被引：0
|
作者：
Shatzel, Joseph J. [1 ]
Daughety, Molly M. [1 ]
DeLoughery, Thomas G. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 375卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2499 / 2499
页数：1
相关论文
共 50 条
  • [41] Deterioration free discharge comparison of andexanet-alfa and prothrombin complex concentrates (PCC) for reversal of factor Xa inhibitor associated bleeds
    Keinath, Jason J.
    Lekura, Jona
    Hauser, Christian D.
    Bajwa, Manisha K.
    Bloome, Michael E.
    Kalus, James S.
    Jones, Mathew C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (02) : 315 - 322
  • [42] Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis
    Nederpelt, Charlie J.
    Naar, Leon
    Krijnen, Pieta
    le Cessie, Saskia
    Kaafarani, Haytham M. A.
    Huisman, Menno V.
    Velmahos, George C.
    Schipper, Inger B.
    CRITICAL CARE MEDICINE, 2021, 49 (10) : E1025 - E1036
  • [43] Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors
    Fera, Toni
    Burnett, Allison
    Grandoni, Jessica
    Moore, Mary R.
    Nussbaum, Barbara B.
    Pollack Jr, Charles V.
    Rose, Anne E.
    Spinler, Sarah A.
    Streiff, Michael B.
    Turck, Charles J.
    Fanikos, John
    JOURNAL OF PHARMACY PRACTICE, 2025, 38 (01) : 7 - 12
  • [44] Modeling the Clinical Implications of Andexanet Alfa in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage
    Chuck, Carlin
    Kim, Daniel
    Kalagara, Roshini
    Rex, Nathaniel
    Madsen, Tracy
    Mahmoud, Leana
    Thompson, Bradford B.
    Jones, Richard N.
    Furie, Karen L.
    Reznik, Michael
    STROKE, 2021, 52
  • [45] Modeling the Clinical Implications of Andexanet Alfa in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage
    Chuck, Carlin C.
    Kim, Daniel
    Kalagara, Roshini
    Rex, Nathaniel
    Madsen, Tracy E.
    Mahmoud, Leana
    Thompson, Bradford B.
    Jones, Richard N.
    Furie, Karen L.
    Reznik, Michael E.
    NEUROLOGY, 2021, 97 (21) : E2054 - E2064
  • [46] Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers.
    Crowther, Mark
    Gold, Alexander M.
    Lu Genmin
    Leeds, Janet M.
    Wiens, Brian L.
    Mathur, Vandana
    Castillo, Janice
    Conely, Pamela B.
    Connolly, Stuart J.
    Curnutte, John T.
    STROKE, 2016, 47
  • [47] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Ammar, Abdalla A.
    Ammar, Mahmoud A.
    Owusu, Kent A.
    Brown, Stacy C.
    Kaddouh, Firas
    Elsamadicy, Aladine A.
    Acosta, Julian N.
    Falcone, Guido J.
    NEUROCRITICAL CARE, 2021, 35 (01) : 255 - 261
  • [48] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    Neurocritical Care, 2021, 35 : 255 - 261
  • [49] Comment on "Emergent external ventricular drain placement in patients with factor Xa inhibitor-associated intracerebral hemorrhage after reversal with andexanet alfa"
    Malik, Ghulam Mustafa Ali
    Kumar, Satesh
    Samiullah
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 232
  • [50] COST COMPARISON OF ANDEXANET VERSUS PCC FOR DIRECT FACTOR XA INHIBITOR REVERSAL AFTER HEMORRHAGE
    Frontera, Jennier
    Joset, Danielle
    Lalchan, Rebecca
    Ahuja, Tania
    Papadopoulis, John
    CRITICAL CARE MEDICINE, 2019, 47
12345